SynthesisFrontiers in pharmacology2025

Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness.

Narcis Cardoner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.